Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Recruiting	Phase 2	2024-11-05		NCT06289062

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Cancer Hospital	32
Beijing Friendship Hospital	120
Gansu Cancer Hospital	7
Qilu Hospital of Shandong University	249
Shengjing Hospital	111
Sichuan Cancer Hospital and Research Institute	64
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285
Third Military Medical University	17
Tianjin Medical University	35
Tongji Hospital	276
West China Second University Hospital	43
Women's Hospital School Of Medicine Zhejiang University	60
Xiangya Hospital of Central South University	162
Zhejiang Cancer Hospital	142

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	34
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	71